Emotional experience is increasingly being measured using experimental tasks, but the stimuli used are often only proxies for the emotion being studied. Stimuli are intended to evoke a distinct emotional experience, but certain designs fail to adequately control for the actual experience in question. In this methodological paper, we review designs used in clinical psychology aimed at measuring emotion and develop the argument of the ‘emotion stimulus critique'. Designs of neuroimaging studies on emotion in this context are given preference. We argue that studies often concentrate on standardization of the stimulus material (i.e. words, images, and movies) for eliciting an emotional experience, whereas standardization of the actual participant's experience is seldom performed. Our proposal discusses the use of standardized stimuli in experimental designs and contrasts this with the necessity of controlling for a participant's unique emotional response. We highlight the importance of each participant's ‘inner metric', i.e. the individual's experiential anchor, which needs to be taken into account when examining the emotional correlates of psychiatric disorders or psychotherapeutic change. Implications of the emotion stimulus critique for research are discussed within the context of psychology, particularly clinical psychology and psychotherapy.

Keywords:
Methods, Emotion, Emotional induction, Stimuli
1.
Lane RD, Ryan L, Nadel L, Greenberg L: Memory reconsolidation, emotional arousal, and the process of change in psychotherapy: new insights from brain Science. Beh Brain Sci 2015;38:e1.
2.
Pascual-Leone A, Paivio S, Harrington S: Emotion in psychotherapy: An experiential-humanistic perspective; in Cain D, Rubin S, Keenan K (eds): Humanistic Psychotherapies: Handbook of Research and Practice, ed 2. Washington, American Psychological Association, 2015.
3.
Rachman R: Emotional processing. Behav Res Ther 1980;18:51-60.
4.
Neacsiu AD, Rizvi SL, Linehan MM: Dialectical behavior therapy skills use as a mediator and outcome of treatment for borderline personality disorder. Behav ResTher 2010;48:832-839.
5.
Schnell K, Herpertz SC: Effects of dialectical-behavioral-therapy on the neural correlates of affective hyperarousal in borderline personality disorder. J Psychiatr Res 2007;41:837-847.
6.
Pascual-Leone A: Dynamic emotional processing in experiential therapy: two steps forward, one step back. J Consult Clin Psychol 2009;77:113-126.
7.
Feist G, Rosenberg E, Stamp J, Poole J: Psychology: Making Connections (Canadian Edition). Whitby, McGraw-Hill Ryerson Higher Education, 2012.
8.
Lewis M, Haviland-Jones JM, Feldman Barrett L: Handbook of Emotions. New York, Guilford Press, 2010.
9.
Siegle GJ, Thompson WK, Collier A, Berman SR, Feldmiller J, Thase ME, Friedman ES: Toward clinically meaningful neuroimaging in depression treatment. Arch Gen Psychiatr 2012;69:913-924.
10.
Sander D: Models of emotion: the affective neuroscience approach; in Armony J, Vuillemier P (eds): The Cambridge Handbook of Human Affective Neuroscience. Cambridge, Cambridge University Press, 2013, pp 5-56.
11.
Banich MT, Compton RJ: Cognitive Neuroscience, ed 3. Wadsworth, Cengage Learning, 2011.
12.
Bradley MM, Lang PJ: Affective Norms for English Words ANEW: Technical Manual and Affective Ratings. Gainsville, The Center for Research in Psychophysiology, University of Florida, 1997.
13.
Schaefer A, Nils F, Sanchez X, Philippot P: Assessing the effectiveness of a large database of emotion-eliciting films: a new tool for emotion researchers. Cogn Emot 2010;24:1153-1172.
14.
Tolman EC, Brunswik E: The organism and the causal texture of the environment. Psychol Rev 1935;42:43-77.
15.
Pascual-Leone J: Can we model organismic causes of working memory, efficiency and fluid intelligence? A meta-subjective perspective. Intelligence 2013;41:738-743.
16.
Watson JB, Rayner R: Conditioned emotional reactions. J Exper Psychol 1920;3:1-4.
17.
Gendlin ET: A theory of personality change; in Worchel P, Byrne D (eds): Personality Change. New York, Wiley, 1964.
18.
Goldfried MR, Davidson GC: Clinical behavior therapy (expanded edition). New York, Wiley-Interscience, 1994.
19.
Cunningham WA, Brosch T: Motivational salience: amygdala tuning from traits, needs, values and goals. Curr Dir Psychol Sci 2012;21:54-59.
20.
Herpertz SC: Affektregulation und ihre neurobiologischen Grundlagen; in Dulz B, Herpertz SC, Sachsse U (eds): Handbuch der Borderline-Störungen, ed 2. Stuttgart, Schattauer, 2011, pp 75-85.
21.
Nabi RL: The theoretical versus the lay meaning of disgust: implications for emotion research. Cogn Emot 2002;16:695-703.
22.
Kuo JR, Neacsiu AD, Fitzpatrick S, MacDonald DE: A methodological examination of emotion inductions in borderline personality disorder: a comparison of standardized versus idiographic stimuli. J Psychopath Behav Assess 2014;36:155-164.
23.
Bradley MM, Lang PJ: Measuring emotion: the self-assessment Manikin and the semantic differential. J Behav Ther Exp Psychiatry 1994;25:49-59.
24.
Niedtfeld I, Kirsch P, Schulze L, Herpertz SC, Bohus M, Schmahl C: Functional connectivity of pain-mediated affect regulation in borderline personality disorder. PLoS One 2012;7:e33293.
25.
Green BG, Shaffer GS, Gilmore MM: Derivation and evaluation of a semantic scale of oral sensation magnitude with apparent ratio properties. Chem Sens 1993;18:683-702.
26.
Lawless HT, Popper R, Kroll BJ: Comparison of the labeled affective magnitude (LAM) scale, an 11-point category scale and the traditional nine-point hedonic scale. Food Qual Pref 2010;21:2-12.
27.
Elices M, Soler J, Fernandez C, Martin-Blanco A, Portella MJ, Perez V, et al: Physiological and self-assessed emotional responses to emotional-eliciting films in borderline personality disorder. Psychiatr Res 2012;200:437-443.
28.
Hooley JM, Siegle G, Gruber SA: Affective and neural reactivity to criticism in individuals high and low on perceived criticism. PLoS One 2012;7:e44412.
29.
Beblo T, Driessen M, Mertens M, Wingenfeld K, Piefke M, Rullkoetter N, et al: Functional MRI correlates of the recall of unresolved life events in borderline personality disorder. Psychol Med 2006;36:845-856.
30.
Whelton WJ, Greenberg LS: Emotion in self-criticism. Pers Individ Diff 2005:38:1583-1595.
31.
Doerig N, Schlumpf Y, Spinell S, Späti J, Brakowski J, Quednow BB, et al: Neural representation and clinically relevant moderators of individualised self-criticism in healthy subjects. Soc Cog Affect Neurosci 2014;9:1333-1340
32.
Youngstrom EA, Green KW: Reliability generalization of self-report of emotions when using the Differential Emotions Scale. Educ Psychol Meas 2003;63:279-295.
33.
Watson D, Clark LA, Tellegen A: Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988;54:1063-1070.
34.
Rochman D, Diamond GM: From unresolved anger to sadness: identifying physiological correlates. J Counsel Psychol 2008;55:96-105.
35.
Pascual-Leone A, Sirois F, Metler S, Singh T, Crozier M, Porter L: Productive emotion in expressive writing: an experimental manipulation of EFT change. Presentation at the 42nd Int Meet Soc Psychother Res, Bern, 2011.
36.
Kamen G, Gabriel DA: Essentials of electromyography. Champaign, Human Kinetics, 2010.
37.
Tausczik YR, Pennebaker JW: The psychological meaning of words: LIWC and computerized text analysis methods. J Lang Soc Psychol 2010;29:24-54.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.